The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 8,001–8,100 of 31,469
Kim, B.-J., Ahn, S. H., Lee, S. H., Hong, S., Hamrick, M. W., Isales, C. M., & Koh, J.-M. (2019) · Aging · doi:10.18632/aging.102068 · Cited by 42
Haufe, S., Kaminski, J., Utz, W., Haas, V., Mähler, A., Daniels, M. A., Birkenfeld, A. L., Lichtinghagen, R., Luft, F. C., Schulz-Menger, J., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000573 · Cited by 41
Pelusi, C., Giagulli, V. A., Baccini, M., Fanelli, F., Mezzullo, M., Fazzini, A., Bianchi, N., Carbone, M. D., De Pergola, G., Mastroroberto, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183369 · Cited by 45
Berezin, A. Е., Kremzer, A. A., Berezina, T. A., et al. (2016) · Acta Clinica Belgica · doi:10.1080/17843286.2015.1110894 · Cited by 45
Gomez, C. L., Santiago‐Fernández, C., García‐Serrano, S., García‐Escobar, E., Gutiérrez‐Repiso, C., Rodriguez, C., Ho‐Plagaro, A., Martín‐Reyes, F., Garrido‐Sánchez, L., Valdés, S., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082615 · Cited by 48
Glucodensities: A new representation of glucose profiles using distributional data analysis
Matabuena, M., Petersen, A., Vidal, J. C., & Gude, F. (2021) · Statistical Methods in Medical Research · doi:10.1177/0962280221998064 · Cited by 47
Wolever, T. M. S., Rahn, M., Dioum, E. M., Spruill, S. E., Ezatagha, A., Campbell, J. E., Jenkins, A. L., & Chu, Y. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab154 · Cited by 56
Gutiérrez, R., Gómez, J. T., Borja‐Urby, R., Soto, J., & Parra, H. (2022) · Molecules · doi:10.3390/molecules27175642 · Cited by 45
Zhang, Y., Qu, Z., Lu, T., Shao, X., Cai, M., Dilimulati, D., Gao, X., Mao, W., Hu, F., Su, L., et al. (2023) · Nutrients · doi:10.3390/nu15030556 · Cited by 52
Reda, D., Elshopakey, G. E., Albukhari, T. A., Almehmadi, S. J., Refaat, B., Risha, E., Mahgoub, H. A., El‐Boshy, M., & Abdelhamid, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1164512 · Cited by 45
Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
Portero‐Otín, M., de la Maza, M. P., & Uribarri, J. (2023) · Cells · doi:10.3390/cells12131684 · Cited by 46
Borja-Magno, A. I., Furuzawa‐Carballeda, J., Guevara‐Cruz, M., Arias, C., Granados, J., Bourges, H., Tovar, A. R., Sears, B., Noriega, L. G., & Gómez, F. E. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109415 · Cited by 45
Zeng, P., Cai, X., Yu, X., & Gong, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-47269-4 · Cited by 45
Sanchez-Garrido, M. A., Serrano-López, V., Ruíz-Pino, F., Vazquez, M. J., Rodríguez-Martín, A., Torres, E., Velasco, I., Rodríguez, A., Chicano‐Gálvez, E., Mora-Ortiz, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52898-y · Cited by 53
Hyun, Y. J., Kim, O. Y., Jang, Y., Ha, J., Chae, J. S., Kim, J. Y., Yeo, H. Y., Paik, J. K., & Lee, J. H. (2008) · Circulation Journal · doi:10.1253/circj.72.1308 · Cited by 43
Lim, S. K., An, J. H., Shin, H., Khang, A. R., Lee, Y., Ahn, H. Y., Yoon, J. W., Kang, S. M., Choi, S. H., Cho, Y. M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04240.x · Cited by 46
Tranchida, F., Shintu, L., Rakotoniaina, Z., Tchiakpe, L., Deyris, V., Hiol, A., & Caldarelli, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135948 · Cited by 45
Nabavi, S., Rafraf, M., Somi, M. H., Rad, A. H., & Jafarabadi, M. A. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.08.031 · Cited by 45
de Luis, D. A., Aller, R., Izaola, O., de la Fuente, B., Conde, R., Sagrado, M. G., & Primo, D. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2323 · Cited by 45
Valenzuela, R., Espinosa, A., Llanos, P., Hernández‐Rodas, M. C., Barrera, C. R., Vergara, D., Romero, N., Pérez, F., Manuel Ruz, O., & Videla, L. A. (2015) · Food & Function · doi:10.1039/c5fo01086a · Cited by 45
Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer
Erdoğan, S., Sezer, S., Başer, E., Eryılmaz, Ö. G., Gungor, T., Uysal, S., & Yılmaz, F. M. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0280 · Cited by 45
A multifaceted school-based intervention to reduce risk for type 2 diabetes in at-risk youth
Grey, M. J., Jaser, S. S., Holl, M. G., Jefferson, V., Dziura, J., & Northrup, V. S. (2009) · Preventive Medicine · doi:10.1016/j.ypmed.2009.07.014 · Cited by 45
Karas, M. G., Benkeser, D. C., Arnold, A. M., Bartz, T. M., Djoussé, L., Mukamal, K. J., Ix, J. H., Zieman, S. J., Siscovick, D. S., Tracy, R. P., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.027 · Cited by 45
Adiponectin and Long-Term Mortality in Coronary Artery Disease Participants and Controls
Hascoët, S., Elbaz, M., Bongard, V., Bouisset, F., Verdier, C., Vindis, C., Genoux, A., Taraszkiewicz, D., Perret, B., Galinier, M., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300079 · Cited by 45
Energy expenditure in obese children with pseudohypoparathyroidism type 1a
Shoemaker, A. H., Lomenick, J. P., Saville, B. R., Wang, W., Buchowski, M. S., & Cone, R. D. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.200 · Cited by 45
Bøhn, S. K., Croft, K. D., Burrows, S., Puddey, I. B., MULDER, T. P. J., Fuchs, D., Woodman, R. J., & Hodgson, J. M. (2014) · Food & Function · doi:10.1039/c4fo00209a · Cited by 45
Contribution of visceral fat accumulation to carotid intima–media thickness in a Chinese population
Wang, Y., Ma, X.-J., Zhou, M., Zong, W., Zhang, L.-L., Hao, Y.-P., Zhu, J.-A., Xiao, Y., Li, D., Bao, Y., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.222 · Cited by 45
Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children
Belo, V. D. A., Souza-Costa, D. C., Luizon, M. R., Lanna, C. M. M., Carneiro, P. C., Izidoro‐Toledo, T. C., Ferraz, K. C., & Tanus-Santos, J. E. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.169 · Cited by 45
Evolution of Lipid Profiles after Bariatric Surgery
Garcia-Marirrodriga, I., Amaya-Romero, C., Ruiz-Diaz, G. P., Fernández, S., Ballesta‐López, C., Pou, J. M., Romeo, J. H., Vilhur, G., Badimón, L., & Ybarra, J. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0534-7 · Cited by 45
Giordano, C. S. D. S., Ciresi, A., Amato, M. C., Pivonello, R., Auriemma, R. S., Grasso, L. F. S., Galluzzo, A., & Colao, A. A. L. (2011) · Pituitary · doi:10.1007/s11102-011-0365-5 · Cited by 45
Reinehr, T., & Wunsch, R. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.06.004 · Cited by 45
de Castro, I. F., Micheloud, D., Berenguer, J., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833ce54d · Cited by 45
Tesauro, M., Rizza, S., Iantorno, M., Campia, U., Cardillo, C., Lauro, D., Leo, R., Turriziani, M., Cocciolillo, G. C., Fusco, A., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.026 · Cited by 45
Argentou, M., TINIAKOS, D. G., Καρανικόλας, Μ., Melachrinou, M., Makri, M. G., Kittas, C. N., & Kalfarentzos, F. E. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9912-9 · Cited by 45
Siqueira, A. C., Cotrim, H. P., Rocha, R., et al. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200508000-00010 · Cited by 45
Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects
Guerrero‐Romero, F., & Rodríguez‐Morán, M. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.014 · Cited by 46
Park, Y.-H., Park, Y.-H., Shin, J. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085068 · Cited by 45
Hayes, L., Pearce, M. S., Firbank, M., Walker, M., Taylor, R., & Unwin, N. C. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-723 · Cited by 47
Yoshino, S., Hamasaki, S., Ishida, S., Kataoka, T., Yoshikawa, A., Oketani, N., Saihara, K., Okui, H., Shinsato, T., Ichiki, H., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.6346 · Cited by 45
Xu, J. Y., Sham, P. C., Xu, A., Tso, A. W. K., Wat, N. M. S., Cheng, K. Y., Fong, C. H.-Y., Janus, E. D., & Lam, K. S. L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02710.x · Cited by 45
Panidis, D., Τζιόμαλος, Κ., Μacut, D., Delkos, D., Betsas, G., Misichronis, G., & Katsikis, I. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.041 · Cited by 44
Vangipurapu, J., Stančáková, A., Pihlajamäki, J., Kuulasmaa, T., Kuulasmaa, T., Paananen, J., Kuusisto, J., Ferrannini, E., & Laakso, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1977-4 · Cited by 45
Momiyama, Y., Ohmori, R., Uto‐Kondo, H., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.6023 · Cited by 45
Glans, F., Elgzyri, T., Shaat, N., Lindholm, E., Apelqvist, J., & Groop, L. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02366.x · Cited by 45
Turchiano, M., Nguyen, C., Fierman, A., Lifshitz, M., & Convit, A. (2013) · Journal of Environmental and Public Health · doi:10.1155/2013/256151 · Cited by 46
Laecke, S. V., Nagler, E. V., Taes, Y., Biesen, W. V., Peeters, P. C., & Vanholder, R. C. (2014) · Transplant International · doi:10.1111/tri.12287 · Cited by 45
Donjacour, C. E. H. M., Aziz, N. A., Overeem, S., Kalsbeek, A., Pijl, H., & Lammers, G. J. (2014) · SLEEP · doi:10.5665/sleep.3592 · Cited by 45
Kang, H., Shim, J., Lee, Y., Linton, J. A., Park, B., & Lee, H.-R. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.06.007 · Cited by 46
Gill, J. M. R., Al-Mamari, A., Ferrell, W. R., Cleland, S. J., Perry, C. G., Sattar, N. A., Packard, C. J., CASLAKE, M. J., & Petrie, J. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.007 · Cited by 45
Effects of obesity/fatty acids on the expression of GPR120
Rodríguez‐Pacheco, F., García‐Serrano, S., García‐Escobar, E., Gutiérrez‐Repiso, C., García-Arnés, J. A., Valdés, S., Gonzalo, M., Soriguer, F., Moreno‐Ruiz, F. J., Rodríguez‐Cañete, A., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300666 · Cited by 45
Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome
Gondoni, L. A., Vismara, L., Marzullo, P., Vettor, R., Liuzzi, A., & Grugni, G. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349255 · Cited by 46
Sales, C. H., dos Santos, A. R., Cintra, D. E., & Colli, C. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.10.004 · Cited by 47
Sleep-related intermittent hypoxemia and glucose intolerance: a community-based study
Tanno, S., Tanigawa, T., Saito, I., Nishida, W., Maruyama, K., Eguchi, E., Sakurai, S., Osawa, H., & Punjabi, N. M. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.05.027 · Cited by 46
Association between flavonoid intake and diabetes risk among the Koreans
Yeon, J., Bae, Y., Kim, E., & Lee, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.042 · Cited by 45
Miele, L., Dall’Armi, V., Cefalo, C., Nedović, B., Arzani, D., Amore, R., Rapaccini, G. L., Gasbarrini, A., Ricciardi, W., Grieco, A., et al. (2014) · Genes & Nutrition · doi:10.1007/s12263-013-0383-1 · Cited by 45
Primary Biliary Cirrhosis is More Severe in Overweight Patients
Híndi, M., Levy, C., Couto, C. A., Bejarano, P. A., & Mendes, F. D. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318261e659 · Cited by 45
Jia, T., Huang, X., Qureshi, A. R., Xu, H., Ärnlöv, J., Lindholm, B., Cederholm, T., Stenvinkel, P., Risérus, U., & Carrero, J. J. (2014) · Kidney International · doi:10.1038/ki.2014.1 · Cited by 45
Lung function, coronary artery calcification, and metabolic syndrome in 4905 Korean males
Park, H. Y., Lim, S. Y., Hwang, J. H., Choi, J., Koh, W., Sung, J., Suh, G. Y., Chung, M. P., Kim, H., Choe, Y. H., et al. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.02.024 · Cited by 45
Trimarco, V., Izzo, R., Stabile, E., Rozza, F., Santoro, M., Manzi, M. V., Serino, F., Schiattarella, G. G., Esposito, G., & Trimarco, B. (2015) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-015-0087-2 · Cited by 46
Impact of Diabetes on Postinfarction Heart Failure and Left Ventricular Remodeling
von Bibra, H., & Sutton, M. S. J. (2011) · Current Heart Failure Reports · doi:10.1007/s11897-011-0070-8 · Cited by 44
Bradnová, O., Kyrou, I., Hainer, V., Včelák, J., Hálková, T., Šrámková, P., Dolezalova, K., Fried, M., McTernan, P. G., Kumar, S., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1143-4 · Cited by 45
Feigh, M., Henriksen, K., Andreassen, K. V., Hansen, C., Henriksen, J. E., Beck‐Nielsen, H., Christiansen, C., & Karsdal, M. A. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01425.x · Cited by 45
Hari, P., Nerusu, K. C., Veeranna, V., Sudhakar, R., ZALAWADIYA, S. K., Ramesh, K., & Afonso, L. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0087 · Cited by 45
“Is there any association between insulin resistance and thyroid cancer? : a case control study”
Balkan, F., Önal, E. D., Usluogullari, A. C., Tüzün, D., Özdemir, D., İnançlı, S. S., Ersoy, R., & Çakır, B. (2013) · Endocrine · doi:10.1007/s12020-013-9942-x · Cited by 45
Li, Y.-C., & Hsieh, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097341 · Cited by 45
Association ofFTOPolymorphisms with Early Age of Obesity in Obese Italian Subjects
Sentinelli, F., Incani, M., Coccia, F., Capoccia, D., Cambuli, V. M., Romeo, S., Cossu, E., Cavallo, M. G., Leonetti, F., & Baroni, M. G. (2012) · Experimental Diabetes Research · doi:10.1155/2012/872176 · Cited by 45
Coccurello, R., Brina, D., Caprioli, A., Conti, R., Ghirardi, O., Schepis, F., & Moles, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181bfe13e · Cited by 44
Effects of pioglitazone on cardiac and adipose tissue pathology in rats with metabolic syndrome
Matsuura, N., Asano, C., Nagasawa, K., Ito, S., Sano, Y., Minagawa, Y., Yamada, Y., Hattori, T., Watanabe, S., Murohara, T., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.099 · Cited by 45
McGeoch, S., Johnstone, A. M., Lobley, G. E., Adamson, J., Hickson, K. A., Holtrop, G., Fyfe, C., Clark, L. F., Pearson, D., Abraham, P., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12228 · Cited by 45
Marinis, L. D., Bianchi, A., Fusco, A., Cimino, V., Mormando, M., Tilaro, L., Mazziotti, G., Pontecorvi, A., & Giustina, A. (2007) · Pituitary · doi:10.1007/s11102-007-0037-7 · Cited by 45
Tissue Plasminogen Activator, von Willebrand Factor, and Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Sattar, N. A., Rumley, A., Whincup, P. H., LENNON, L. T., & Lowe, G. D. O. (2008) · Diabetes Care · doi:10.2337/dc07-1569 · Cited by 45
Matsuo, T., So, R., Shimojo, N., & Tanaka, K. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.05.009 · Cited by 44
Fang, Q., Li, H., Song, Q., Yang, W. J., Hou, X., Ma, X., Lu, J., Xu, A., & Jia, W. (2013) · Diabetes Care · doi:10.2337/dc12-1766 · Cited by 45
Celik, C., Abalı, R., Baştu, E., Taşdemir, N., Tasdemir, U. G., & Gul, A. (2013) · Human Reproduction · doi:10.1093/humrep/det002 · Cited by 46
The relation between insulin resistance and lung function: a cross sectional study
Sağun, G., Gedik, C., Ekiz, E., et al. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0125-9 · Cited by 45
The TCF7L2rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population
Ouhaïbi-Djellouli, H., Médiène-Benchekor, S., Lardjam-Hetraf, S. A., Hamani-Medjaoui, I., Meroufel, D. N., Boulenouar, H., Hermant, X., Saïdi‐Mehtar, N., Amouyel, P., Houti, L., et al. (2014) · BMC Genetics · doi:10.1186/s12863-014-0134-3 · Cited by 45
Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin
Aghili, R., Malek, M., Valojerdi, A. E., Banazadeh, Z., Najafi, L., & Khamseh, M. E. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0088-z · Cited by 47
Pallayová, M., Steele, K. E., Magnuson, T. H., Schweitzer, M., Hill, N. R., Bevans‐Fonti, S., & Schwartz, A. R. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-83 · Cited by 44
Livadas, S., Κόλλιας, Α., Panidis, D., & Diamanti‐Kandarakis, E. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1007 · Cited by 45
Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans
Kim, M., Na, W., & Sohn, C. (2013) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.12-81 · Cited by 45
Inflammation and Hypertension in Rheumatoid Arthritis
Manavathongchai, S., Bian, A., Rho, Y. H., et al. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130394 · Cited by 45
Won, J. C., Park, C., Park, H.-S., Kim, J. H., Choi, E. S., Rhee, E., Lee, W., Oh, K. W., Kim, S. W., & Park, S. W. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.01.002 · Cited by 45
FILIPPO, G. D., Rendina, D., Moccia, F. D., Rocco, V., & Campanozzi, A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0176-4 · Cited by 45
Onambélé-Pearson, G. L., Breen, L., & Stewart, C. E. (2010) · AGE · doi:10.1007/s11357-010-9141-0 · Cited by 49
Pregestational maternal obesity impairs endocrine pancreas in male F1 and F2 progeny
Graus‐Nunes, F., Frantz, E. D. C., Lannes, W. R., Menezes, M. C. D. S., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2014) · Nutrition · doi:10.1016/j.nut.2014.08.002 · Cited by 45
Medina‐Bravo, P., Meza-Santibáñez, R., Rosas-Fernández, P., Galván-Duarte, R. E., Saucedo, R., López, L. V., & Torres‐Tamayo, M. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.03.002 · Cited by 45
Willette, A., Bendlin, B., Colman, R., Kastman, E. K., Field, A., Alexander, A., Sridharan, A., Allison, D., Anderson, R. M., Voytko, M., et al. (2012) · Diabetes · doi:10.2337/db11-1187 · Cited by 48
Ito, H., Ohshima, A., Tsuzuki, M., Ohto, N., Takao, K., Hijii, C., Yanagawa, M., Ogasawara, M., & Nishioka, K. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03429.x · Cited by 43
Diabetes mellitus in patients with thalassemia major
Li, M., Peng, S. S., Lu, M., Chang, H., Yang, Y., Jou, S., Lin, D., & Lin, K. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24754 · Cited by 46
Qin, Y., & Tian, Y. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-78 · Cited by 45
Williams, D. M., Fraser, A., Fraser, W. D., Hyppönen, E., Smith, G. D., Deanfield, J. E., Hingorani, A. D., Sattar, N. A., & Lawlor, D. A. (2013) · Heart · doi:10.1136/heartjnl-2013-303678 · Cited by 45
Resveratrol Protects against Methylglyoxal-Induced Hyperglycemia and Pancreatic Damage In Vivo
Cheng, A.-S., Cheng, Y.-H., Lee, C., Chung, C.-Y., & Chang, W.-C. (2015) · Nutrients · doi:10.3390/nu7042850 · Cited by 45
Hwang, K.-A., Hwang, Y.-J., Kim, G. R., & Choe, J. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0871-5 · Cited by 46
Kotani, K., Satoh, N., Kato, Y., Araki, R., Koyama, K., Okajima, T., Tanabe, M., Oishi, M., Yamakage, H., Yamada, K. D., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.017 · Cited by 46
Insulin Resistance and LVH Progression in Patients With Calcific Aortic Stenosis
Capoulade, R., Clavel, M.-A. A., Dumesnil, J. G., Chan, K. L., Teo, K. K., Tam, J. W., Côté, N., Mathieu, P., Després, J., & Pîbarot, P. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.11.004 · Cited by 44
Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders
Ibarretxe, D., Girona, J., Plana, N., Cabré, A., Ferré, R., Amigó, N., Guaita, S., Mallol, R., Heras, M., & Masana, L. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.11.001 · Cited by 47
Baron, K. G., Reid, K. J., Malkani, R. G., Kang, J., & Zee, P. C. (2016) · Behavioral Sleep Medicine · doi:10.1080/15402002.2015.1120200 · Cited by 50
Ghiasi, R., Soufi, F. G., Somi, M. H., Mohaddes, G., Bavil, F. M., Naderi, R., & Alipour, M. R. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.052 · Cited by 47
The effects of voluntary exercise on oocyte quality in a diet-induced obese murine model
Boudoures, A. L., Chi, M. M.-Y., Thompson, A. S., Zhang, W., & Moley, K. H. (2015) · Reproduction · doi:10.1530/rep-15-0419 · Cited by 45
Maithilikarpagaselvi, N., Sridhar, M. G., Swaminathan, R. P., & Sripradha, R. (2016) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2015-0070 · Cited by 47
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
